The Tomorrow David Bowie Missed

“Tomorrow belongs to those who can hear it coming.” — David Bowie

David Bowie heard it before the rest of us. He was the astronaut of culture, launching transmissions from futures that felt both alien and inevitable. In 1969 the world looked up as Apollo 11 landed on the moon, and Bowie answered with Space Oddity, sending Major Tom adrift above a blue planet. Three years later Ziggy Stardust descended in glitter and warning, telling us we had five years left. I was only a child, too young to decode the message, but the signal was unmistakable. Bowie was broadcasting from tomorrow.

While Bowie was staging transmissions from the cosmos, America was launching its own cosmic metaphor. In 1971 Nixon signed the National Cancer Act and declared a “War on Cancer,” modeled on the space race. If we could put a man on the moon, the thinking went, surely we could conquer cancer with the same national will. Curing cancer became the ultimate moonshot.

But medicine lagged. By the time Bowie died in 2016 of liver cancer, the war was in its fifth decade. Science had mapped mutations and built the scaffolding for targeted drugs, yet the treatments for his disease were still blunt instruments. They could slow a tumor but rarely stop it. Median survival was measured in months. His 18-month course was typical.

Bowie turned those months into art, shaping Blackstar as a final transmission from the edge of life. His body was fixed in 2016. His imagination was still years ahead. Today, medicine is finally catching up. Where once it could only delay the inevitable, it now has the precision to extend life in ways that might have given Bowie more time. Time to choose when and how to make his exit.

The New Moonshot: Precision Medicine

The War on Cancer borrowed the moonshot metaphor, but what followed looked more like trench warfare than rocket flight. Chemotherapy and radiation scorched entire landscapes, trying to kill the enemy faster than the host. Progress came, but it was slow, uneven, and costly.

Precision medicine is different. It begins by sequencing the tumor itself. Every cancer carries its own code, and reading that code unlocks new possibilities: which switches are flipped on or off, which pathways are driving growth, which weak points can be targeted. Instead of one-size-fits-all, treatment becomes patient by patient, tumor by tumor.

Now doctors can track disease almost in real time. Liquid biopsies pick up fragments of DNA in the blood that signal new mutations months before a scan. Circulating tumor cells reveal whether cancer is staying put or preparing to spread. That knowledge means treatment can adapt mid-course, correcting trajectory instead of waiting for collapse.

This is medicine’s Apollo moment, not in size but in precision. Apollo didn’t succeed by building the biggest rocket. It succeeded by mastering angles, course corrections, and re-entry. Precision medicine is doing the same with biology. The mantra is simple: sequence, treat, monitor, adapt, repeat.

The tools multiplying around this core are astonishing. Personalized vaccines can now be designed from the unique mutations of a single tumor. Engineered immune cells are learning to enter solid tumors and dismantle them from within. But the ultimate enabler is AI. The knowledge explosion of modern biology is already beyond human scale, and so is the complexity of cancer. AI can sift through billions of data points—genomes, proteins, clinical outcomes—and find the patterns no human mind could hold. It will design drugs in weeks that would once have taken decades. It can match therapies to patients with the speed and accuracy of mission control correcting a spacecraft mid-flight.

When Nixon declared war, the metaphor was borrowed. Today it is literal. We are launching patient by patient. Biology is the rocket. AI is the navigation system. And time is the fuel. The mission is not one dramatic flag-planting, but a series of controlled burns that carry each patient far enough to reach the next breakthrough waiting ahead.

The Exponential Horizon

The hardest truth is that you don’t have to win outright. You only need to survive long enough to reach the next breakthrough. That is the essence of exponential progress. Medicine doesn’t move like a straight road. It advances like rocket stages, each one falling away only after it has carried you far enough to ignite the next.

The pace is staggering. Sequencing a genome once cost millions; today it costs no more than a dinner for two. AI solved protein folding in a single leap, opening entire new maps of biology. Vaccines that once took years can now be built in months. Engineered cells that were once fantasy are already treating patients. From a distance, you can see the rocket accelerating.

But inside the fight, it rarely feels that way. For a patient waiting on a scan or enduring another round of treatment, progress moves no faster than the calendar. Breakthroughs arrive as headlines long before they reach the bedside. The handoffs are real, but you usually only see them in hindsight.

That’s why survival itself becomes the strategy. Immunotherapy might buy a year or two. That year can carry someone to the next option, and then the one after that. Each stage is a bridge, even if at the time it feels like standing still. AI is collapsing timelines further, compressing decades of trial and error into months and matching therapies to patients as the science evolves. Each handoff changes the math. Survival is no longer an endpoint, but a bridge to the next frontier.

Bowie would have understood this rhythm instinctively. His art was never about delivering the whole future in one gesture. He reinvented himself in cycles, each persona carrying him just far enough to make the next one possible. That is medicine’s model now: a chain of survivals, each improbable on its own, but together adding up to something extraordinary.

The tragedy is that Bowie’s timeline missed this acceleration. The rocket was ready, but his body could not wait for ignition. The hope for the rest of us is that we can.

Bowie’s Last Transmission

I didn’t discover Bowie until college in the late ’80s, by which time he was already a constellation of past personas: Ziggy, Major Tom, the Man Who Fell to Earth. His music was timeless, melancholy, and strangely intimate. I was studying physics and dreaming of galaxies, but his vision of the future was more moving than equations. He made space into something human: beautiful, lonely, and fragile.

That same pull toward the future shaped my own path. When I set out on my career and started my first venture in a dorm room, I chose healthcare because it was where the biggest problems lived in the biggest industry, and because people were more interesting than particles. Bowie’s life showed that the future is never abstract. It is always personal, and it always demands courage to meet it.

That is what precision medicine feels like now. We are staring into a vast biological universe, intricate and strange, knowing survival depends on learning to navigate it. Bowie inhabited that future through art. Medicine is only now beginning to live in it, powered by AI’s ability to decode what was once unknowable in our biology.

The new moonshot isn’t aimed outward at the stars. It is aimed inward, at the galaxies of genes and proteins inside us. The task is brutally simple: survive long enough for the next discovery, and then the one after that. Bowie showed us how to live in tomorrow before it arrived. Medicine’s challenge is to catch up so fewer of us miss the tomorrow Bowie never reached.